342 related articles for article (PubMed ID: 20200160)
41. Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells.
Won J; Yim J; Kim TK
J Biol Chem; 2002 Oct; 277(41):38230-8. PubMed ID: 12151407
[TBL] [Abstract][Full Text] [Related]
42. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
Zhang Y; Dufau ML
J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
[TBL] [Abstract][Full Text] [Related]
43. Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex.
Sun G; Porter W; Safe S
Mol Endocrinol; 1998 Jun; 12(6):882-90. PubMed ID: 9626663
[TBL] [Abstract][Full Text] [Related]
44. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators.
An J; Ribeiro RC; Webb P; Gustafsson JA; Kushner PJ; Baxter JD; Leitman DC
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15161-6. PubMed ID: 10611355
[TBL] [Abstract][Full Text] [Related]
45. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
Al-Dhaheri MH; Rowan BG
Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
[TBL] [Abstract][Full Text] [Related]
46. Transcriptional activation of rat creatine kinase B by 17beta-estradiol in MCF-7 cells involves an estrogen responsive element and GC-rich sites.
Wang F; Samudio I; Safe S
J Cell Biochem; 2001; 84(1):156-72. PubMed ID: 11746525
[TBL] [Abstract][Full Text] [Related]
47. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
Laganière J; Deblois G; Giguère V
Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
[TBL] [Abstract][Full Text] [Related]
48. Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.
De Amicis F; Zupo S; Panno ML; Malivindi R; Giordano F; Barone I; Mauro L; Fuqua SA; Andò S
Mol Endocrinol; 2009 Apr; 23(4):454-65. PubMed ID: 19147702
[TBL] [Abstract][Full Text] [Related]
49. ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line.
Varshochi R; Halim F; Sunters A; Alao JP; Madureira PA; Hart SM; Ali S; Vigushin DM; Coombes RC; Lam EW
J Biol Chem; 2005 Feb; 280(5):3185-96. PubMed ID: 15557281
[TBL] [Abstract][Full Text] [Related]
50. Repression of cancer protective genes by 17beta-estradiol: ligand-dependent interaction between human Nrf2 and estrogen receptor alpha.
Ansell PJ; Lo SC; Newton LG; Espinosa-Nicholas C; Zhang DD; Liu JH; Hannink M; Lubahn DB
Mol Cell Endocrinol; 2005 Nov; 243(1-2):27-34. PubMed ID: 16198475
[TBL] [Abstract][Full Text] [Related]
51. ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases.
Lopez-Garcia J; Periyasamy M; Thomas RS; Christian M; Leao M; Jat P; Kindle KB; Heery DM; Parker MG; Buluwela L; Kamalati T; Ali S
Nucleic Acids Res; 2006; 34(21):6126-36. PubMed ID: 17085477
[TBL] [Abstract][Full Text] [Related]
52. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
van de Stolpe A; Slycke AJ; Reinders MO; Zomer AW; Goodenough S; Behl C; Seasholtz AF; van der Saag PT
Mol Endocrinol; 2004 Dec; 18(12):2908-23. PubMed ID: 15345745
[TBL] [Abstract][Full Text] [Related]
53. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
54. Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect.
Teyssier C; Belguise K; Galtier F; Cavailles V; Chalbos D
Mol Endocrinol; 2003 Feb; 17(2):287-99. PubMed ID: 12554755
[TBL] [Abstract][Full Text] [Related]
55. Sp1 and Sp3 regulate basal transcription of the human CYP2F1 gene.
Wan J; Carr BA; Cutler NS; Lanza DL; Hines RN; Yost GS
Drug Metab Dispos; 2005 Aug; 33(8):1244-53. PubMed ID: 15860659
[TBL] [Abstract][Full Text] [Related]
56. Exchange of a nuclear corepressor between NF-kappaB and CREB mediates inhibition of phosphoenolpyruvate carboxykinase transcription by NF-kappaB.
Yan JH; Gao ZG; Ye JP; Weng JP
Chin Med J (Engl); 2010 Jan; 123(2):221-6. PubMed ID: 20137375
[TBL] [Abstract][Full Text] [Related]
57. Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes.
Castet A; Herledan A; Bonnet S; Jalaguier S; Vanacker JM; Cavaillès V
Mol Endocrinol; 2006 May; 20(5):1035-47. PubMed ID: 16439465
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.
Li X; Mertens-Talcott SU; Zhang S; Kim K; Ball J; Safe S
Endocrinology; 2010 Jun; 151(6):2462-73. PubMed ID: 20382698
[TBL] [Abstract][Full Text] [Related]
59. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site.
Salvatori L; Pallante P; Ravenna L; Chinzari P; Frati L; Russo MA; Petrangeli E
Oncogene; 2003 Jul; 22(31):4875-81. PubMed ID: 12894229
[TBL] [Abstract][Full Text] [Related]
60. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
Loeffler S; Fayard B; Weis J; Weissenberger J
Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
